CLVLF
Price
$7.33
Change
+$0.38 (+5.47%)
Updated
Jun 4 closing price
Capitalization
337.02M
QNRX
Price
$8.82
Change
+$0.06 (+0.68%)
Updated
Jun 6 closing price
Capitalization
5.15M
Interact to see
Advertisement

CLVLF vs QNRX

Header iconCLVLF vs QNRX Comparison
Open Charts CLVLF vs QNRXBanner chart's image
Clinuvel Pharmaceuticals
Price$7.33
Change+$0.38 (+5.47%)
Volume$200
Capitalization337.02M
Quoin Pharmaceuticals
Price$8.82
Change+$0.06 (+0.68%)
Volume$8.07K
Capitalization5.15M
CLVLF vs QNRX Comparison Chart
Loading...
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLVLF vs. QNRX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLVLF is a Hold and QNRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CLVLF: $6.95 vs. QNRX: $9.37)
Brand notoriety: CLVLF and QNRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLVLF: 217% vs. QNRX: 4%
Market capitalization -- CLVLF: $337.02M vs. QNRX: $5.15M
CLVLF [@Biotechnology] is valued at $337.02M. QNRX’s [@Biotechnology] market capitalization is $5.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLVLF’s FA Score shows that 1 FA rating(s) are green whileQNRX’s FA Score has 2 green FA rating(s).

  • CLVLF’s FA Score: 1 green, 4 red.
  • QNRX’s FA Score: 2 green, 3 red.
According to our system of comparison, QNRX is a better buy in the long-term than CLVLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QNRX’s TA Score shows that 5 TA indicator(s) are bullish.

  • QNRX’s TA Score: 5 bullish, 4 bearish.

Price Growth

CLVLF (@Biotechnology) experienced а 0.00% price change this week, while QNRX (@Biotechnology) price change was +10.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLVLF($337M) has a higher market cap than QNRX($5.15M). CLVLF YTD gains are higher at: -17.751 vs. QNRX (-58.857).
CLVLFQNRXCLVLF / QNRX
Capitalization337M5.15M6,545%
EBITDA63.4MN/A-
Gain YTD-17.751-58.85730%
P/E Ratio14.80N/A-
Revenue91.6MN/A-
Total CashN/A2.86M-
Total DebtN/A6.21M-
FUNDAMENTALS RATINGS
CLVLF vs QNRX: Fundamental Ratings
CLVLF
QNRX
OUTLOOK RATING
1..100
3735
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
4598
PRICE GROWTH RATING
1..100
7859
P/E GROWTH RATING
1..100
931
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLVLF's Valuation (3) in the null industry is in the same range as QNRX (20) in the Biotechnology industry. This means that CLVLF’s stock grew similarly to QNRX’s over the last 12 months.

CLVLF's Profit vs Risk Rating (100) in the null industry is in the same range as QNRX (100) in the Biotechnology industry. This means that CLVLF’s stock grew similarly to QNRX’s over the last 12 months.

CLVLF's SMR Rating (45) in the null industry is somewhat better than the same rating for QNRX (98) in the Biotechnology industry. This means that CLVLF’s stock grew somewhat faster than QNRX’s over the last 12 months.

QNRX's Price Growth Rating (59) in the Biotechnology industry is in the same range as CLVLF (78) in the null industry. This means that QNRX’s stock grew similarly to CLVLF’s over the last 12 months.

QNRX's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for CLVLF (93) in the null industry. This means that QNRX’s stock grew significantly faster than CLVLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QNRX
RSI
ODDS (%)
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
85%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
87%
Declines
ODDS (%)
Bearish Trend 28 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CLVLF and

Correlation & Price change

A.I.dvisor tells us that CLVLF and IONS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLF and IONS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLVLF
1D Price
Change %
CLVLF100%
N/A
IONS - CLVLF
28%
Poorly correlated
-2.67%
MCRB - CLVLF
24%
Poorly correlated
-2.49%
PXXLF - CLVLF
23%
Poorly correlated
N/A
NICXF - CLVLF
22%
Poorly correlated
N/A
QNRX - CLVLF
22%
Poorly correlated
-4.97%
More

QNRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNRX has been loosely correlated with ATNF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if QNRX jumps, then ATNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
-4.97%
ATNF - QNRX
33%
Loosely correlated
-3.89%
WVE - QNRX
32%
Poorly correlated
+1.85%
PRQR - QNRX
29%
Poorly correlated
N/A
ALGS - QNRX
29%
Poorly correlated
+3.58%
KRRO - QNRX
26%
Poorly correlated
-3.12%
More